Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation.

Thomas Jensen,Pernille G Thrane,Kevin K W Olesen,Morten Würtz,Martin Bødtker Mortensen,Christine Gyldenkerne,Troels Thim,Bjarne Linde Nørgaard,Jesper Møller Jensen,Steen Dalby Kristensen,Jens C Nielsen,John W Eikelboom,Michael Maeng

European heart journal. Cardiovascular pharmacotherapy（2023）

引用 1|浏览55

暂无评分

摘要

Our results support long-term OAC monotherapy beyond 1 year after PCI in patients with atrial fibrillation and suggest that DOAC monotherapy is as safe and effective as VKA monotherapy.

查看译文

关键词

Atrial fibrillation,Bleeding,Cohort study,Percutaneous coronary intervention,Thromboembolism

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要